Howard A. “Skip” Burris III, MD: An Oncology Pioneer Reflects on Patients, Progress, and Purpose

Key Points

• The paper aims to explore the career reflections of an oncology pioneer in drug development.
• Reflective narrative of the author's experiences and contributions to oncology and drug development.
• Discussion of his role in establishing the phase 1 drug development program at the Sarah Cannon Research Institute.
• Highlighting advancements in oncology treatments over the years.
• Emphasizing the importance of patient-centered care in cancer research and treatment.